“…We found that relevant genes from PMSN‐mediated SDT were mainly involved in interleukin‐1 production, positive regulation of superoxide anion generation, positive regulation of inflammasome complex regulation of inflammatory response, pyroptosis, cysteine‐type endopeptidase activity involved in apoptotic process, cysteine‐type endopeptidase activator activity, and cytokine receptor binding in GO analysis (Figure S19b, Supporting Information). Additionally, among the genes, we selected 23 pyroptosis‐ ( Casp3, Casp4, Casp1, Casp9, Casp8, Gsdme, Gsdmd, Gsdmc, Gsdma, Nlrc4, Nlrp3, Pycard, Naip2, Aim2 Pjvk , and Nlrp1 ) and pro‐inflammatory cytokine‐ ( Il18, Il1b, Tnf, Il6, Ila, Csf2 , and Csf1 ) related genes [ 38 ] from identified differentially expressed genes (DEGs). After PMSN+US treatment, Casp3, Gsdme, Naip2 , and Il18 had significant upregulation ( p < 0.005), Casp4, Casp1, Casp9, Casp8, Gsdmd, Nlrc4, Nlrp3, Il1b , and Tnf were also enriched in tumors ( p < 0.05), while Pjvk and Nlrp1 were downregulated ( p < 0.05) when comparing to the NTC group (Figure 3i).…”